Enterprise Value
101.1M
Cash
39.92M
Avg Qtr Burn
-7.769M
Short % of Float
22.20%
Insider Ownership
8.26%
Institutional Own.
23.93%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Deramiocel (CAP-1002) Details Duchenne muscular dystrophy | Phase 2 Update | |
CAP-1002 Details COVID-19 | Failed Discontinued |